Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

FDA clears Abbott's Libre Duo 10 Day wearable sensor for glucose and ketone monitoring in diabetes
Medical device, metabolic, continuous glucose monitoring, diabetic ketoacidosis, type 1 diabetes, SGLT2 inhibitors - Read more

Roche wins expanded FDA clearance for HER2 diagnostics tied to Jazz Pharmaceuticals' Ziihera in metastatic gastroesophageal adenocarcinoma
Antibody, cancer, antibody-drug conjugate, gastric cancer, HER2, companion diagnostic - Read more

Revolution Medicines' Rasonque (daraxonrasib) wins FDA approval for second-line pancreatic ductal adenocarcinoma, targeting RAS
Small molecule, cancer, RAS inhibitor, pancreatic cancer, non-small cell lung cancer, KRAS - Read more

ViiV Healthcare's Tivicay PD (dolutegravir) receives FDA approval for human immunodeficiency virus type 1 infection in pediatric patients weighing at least 2 kg
Small molecule, infectious disease, HIV-1, antiretroviral, integrase strand transfer inhibitor, paediatric patients - Read more

ProFound Therapeutics, Gates Foundation partner on preeclampsia target discovery, $35M deal with $20M upfront
Research collaboration, women's health, AI/ML, drug discovery, milestone payments, proteomics - Read more

Osivax licenses GC FLU from GC Biopharma to develop combination influenza vaccine with OVX836
Licensing deal, infectious disease, vaccine, royalties, co-development - Read more

Noetik, GSK hit first milestone in five-year AI oncology collaboration, $50M upfront
Licensing deal, oncology, AI/ML, drug discovery, milestone payments - Read more

Cell and Gene Live is a one-day, investor & CEO summit dedicated exclusively to Cell and Gene therapy - the science, the manufacturing, and the investment driving advanced medicines forward. All happening on November 15, 2026.

(Hosted by Onyx at The Shard in London as part of London Life Sciences Week)

Speakers confirmed include:

• Steve Bates, OBE (Chair of the UK's Department of Life Sciences)
• Dr. Erik Wiklund (CEO of Circio)
• Edwin Stone (CEO of Cellular Origins)
+ many more!

Get your tickets here - for TLDR Biotech readers, use code ANIS20 at check-out for 20% off.

AstraZeneca, Amgen's Tezspire (tezepelumab) hits Ph3 endpoints in eosinophilic esophagitis, targeting TSLP pathway
Antibody, autoimmune, monoclonal antibody, eosinophilic esophagitis, TSLP, Tezspire - Read more

TRexBio's TRB-061 (TRB-061) shows positive Ph1 results as TNFR2 agonist for moderate-to-severe atopic dermatitis
Antibody, autoimmune, TNFR2 agonist, atopic dermatitis, regulatory T cells - Read more

CSPC Pharmaceutical Group's (SYS6010) meets primary endpoint in Ph3 trial for epidermal growth factor receptor-mutated non-small cell lung cancer
Antibody-drug conjugate, cancer, non-small cell lung cancer, EGFR, TKI-resistant - Read more

Mesoblast reports US$120M revenue with US$104M gross profit in FY2026 financial results
Cell therapy, autoimmune, financial, revenue impact - Read more

Arctic Bioscience reports 35.2% revenue growth in H1 2026, advances HRO350 HeROPA trial publications
Nutraceutical, dermatology, revenue impact, financial - Read more

CEPI commits up to $16.5M to advance Minapharm's Bundibugyo Ebola vaccine into clinical trials
Infectious disease, vaccine, viral vector, preclinical, modified vaccinia Ankara - Read more

Jazz Pharmaceuticals prices upsized $1.1B exchangeable senior notes offering due 2032, general corporate purposes
Specialty pharma, neurology, oncology, small molecule - Read more

Faro AI raises $37.3M Series B, scaling agentic AI across clinical development workflows
Agentic AI, clinical development, software platform, AI-driven - Read more

Artis BioSolutions opens Spanish facility, expanding synthetic DNA and mRNA production capabilities for genetic medicines.
mRNA, genetic medicines, operational, manufacturing - Read more

Biosidus expands bioreactor capacity, boosting global supply of agalsidase beta for Fabry disease
Biosimilar enzyme replacement therapy, rare disease, operational, major transaction - Read more

Trump to unveil MFN drug pricing deals with mid-sized biopharma companies, offering tariff relief incentives
Drug pricing, biopharma, regulatory, financial - Read more

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

Vitruvias Therapeutics recalls 3,655 superpotent thyroid tablets, ceases operations, transfers products to H2-Pharma
Small molecule, endocrine, recall, operational - Read more

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here